Device Trial Radar · NCT06406790
CraniSeal Post Approval Study
Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
224
Planned (sponsor's estimate)
Start
May 29, 2024
Primary completion
Feb 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- Pramand LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant. The study has been powered specifically to determine whether the CraniSeal device when used as an adjunct to sutured dural closure following elective cranial surgery is no worse than (i.e., non-inferior) to the DuraSeal device with respect to proportion of subjects free from post-operative cerebrospinal fluid (CSF) leaks. Additional safety outcomes (i.e., surgical site infections and adverse events/device-related adverse events) will also be captured and compared.
Conditions
- Leak, Cerebrospinal Fluid
Interventions
CraniSealDevice
CraniSeal is a PEG Dural Sealant
DuraSealDevice
DuraSeal is a PEG Dural Sealant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absence of CSF LeaksTime frame: 90 days
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Keck Medical Center at USC
Los Angeles, California · Completed
Mayo Clinic
Jacksonville, Florida · Recruiting
Tampa General Hospital
Tampa, Florida · Recruiting
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.